Madagascar Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Madagascar Health Press.

Press releases published on June 30, 2026

6 hours ago

Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board

Indeterminate GlobeNewswire

6 hours ago

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer

Indeterminate GlobeNewswire

6 hours ago

Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

Indeterminate GlobeNewswire

6 hours ago

Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer

Indeterminate GlobeNewswire

6 hours ago

Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

Indeterminate GlobeNewswire

6 hours ago

Provectus Biopharmaceuticals and VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular Infections

Indeterminate GlobeNewswire

6 hours ago

Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease

Indeterminate GlobeNewswire

6 hours ago

Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1

Indeterminate GlobeNewswire

6 hours ago

U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA

Indeterminate GlobeNewswire

6 hours ago

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

Indeterminate GlobeNewswire

6 hours ago

Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet

Indeterminate GlobeNewswire

6 hours ago

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors

Indeterminate GlobeNewswire

6 hours ago

Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding

Indeterminate GlobeNewswire

6 hours ago

InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

Indeterminate GlobeNewswire

6 hours ago

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

Indeterminate GlobeNewswire

7 hours ago

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

Indeterminate GlobeNewswire

7 hours ago

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease

Indeterminate GlobeNewswire

7 hours ago

R1 Therapeutics establishes world-class Scientific Advisory Board to support advancement of AP306 in Chronic Kidney Disease

Indeterminate GlobeNewswire

7 hours ago

Beeline Medicines Announces Upsized Series A of $426.3 Million to Advance Category-Leading Autoimmune and Inflammatory Disease Portfolio

Indeterminate GlobeNewswire

7 hours ago

Tilray Beer Brands SweetWater, 10 Barrel, Breckenridge, BrewDog, Montauk, Blue Point, Hop Valley and Terrapin Tap into America’s 250th with Fourth of July Celebrations Nationwide

Indeterminate GlobeNewswire